Literature DB >> 9766558

HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia.

G Y Ho1, A S Kadish, R D Burk, J Basu, P R Palan, M Mikhail, S L Romney.   

Abstract

Although genital human papillomavirus (HPV) infection is well established as the etiologic agent for cervical intraepithelial neoplasia (CIN), little is known about the cofactors involved in the development of high-grade lesions or the progression of low-grade to high-grade lesions. In our study of HPV-infected women with CIN (163 CIN I, 51 CIN II and 44 CIN III), women with CIN II or III were compared with those with CIN I for risk factors associated with high-grade lesions. After controlling for age, education, ethnicity and frequency of Pap smear screening, infection with HPV 16, but not high viral load or infection with multiple types, was associated with high-grade lesions (OR for CIN II = 11.96, OR for CIN III = 23.74). Risk of CIN III, but not CIN II, increased with number of cigarettes smoked per day (ORs = 1.49 and 3.35 for < or = 10 and > 10 cigarettes per day, respectively) and decreased with frequency of condom use during sex (ORs = 0.60 and 0.32 for women who used condoms occasionally/sometimes and most/all of the time, respectively). There were no associations between high-grade lesions and plasma levels of micronutrients (retinol, beta-carotene, alpha-tocopherol and reduced ascorbic acid). Our results indicate that infection with HPV 16 is associated with high-grade lesions. Additional cofactors, such as cigarette smoking, may be required as a carcinogen to advance HPV-infected cells toward neoplastic progression.

Entities:  

Mesh:

Year:  1998        PMID: 9766558     DOI: 10.1002/(SICI)1097-0215(19981029)78:3<281::AID-IJC3>3.0.CO;2-R

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Association of oncogenic human papillomavirus DNA with high grade cervical intraepithelial neoplasia: the role of cigarette smoking.

Authors:  S F Derchain; C M Roteli-Martins; K J Syrjänen; H J de Abreu; E Z Martinez; V A Alves
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

2.  Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009.

Authors:  Benjamin M Craig; Marc Brisson; Harrell Chesson; Anna R Giuliano; Mark Jit
Journal:  Clin Ther       Date:  2010-08       Impact factor: 3.393

Review 3.  Expanding the scope of nursing research in low resource and middle resource countries, regions, and states focused on cervical cancer prevention, early detection, and control.

Authors:  Sandra Millon Underwood; Edith Ramsay-Johnson; Asante Dean; Jori Russ; Ruth Ivalis
Journal:  J Natl Black Nurses Assoc       Date:  2009-12

4.  Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

Authors:  Cornelia L Trimble; Steven Piantadosi; Patti Gravitt; Brigitte Ronnett; Ellen Pizer; Andrea Elko; Barbara Wilgus; William Yutzy; Richard Daniel; Keerti Shah; Shiwen Peng; Chienfu Hung; Richard Roden; Tzyy Choou Wu; Drew Pardoll
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

Review 5.  Human papillomavirus, smoking, and head and neck cancer.

Authors:  Parul Sinha; Henrietta L Logan; William M Mendenhall
Journal:  Am J Otolaryngol       Date:  2011-05-05       Impact factor: 1.808

6.  Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.

Authors:  Chang Sun; Laura L Reimers; Robert D Burk
Journal:  Gynecol Oncol       Date:  2011-04       Impact factor: 5.482

7.  Active and passive cigarette smoking and the risk of cervical neoplasia.

Authors:  Cornelia L Trimble; Jeanine M Genkinger; Alyce E Burke; Sandra C Hoffman; Kathy J Helzlsouer; Marie Diener-West; George W Comstock; Anthony J Alberg
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

Review 8.  A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States.

Authors:  Ralph P Insinga; Kai-Li Liaw; Lisa G Johnson; Margaret M Madeleine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

9.  Factors affecting the detection rate of human papillomavirus.

Authors:  Diane M Harper; Meghan R Longacre; Walter W Noll; Dorothy R Belloni; Bernard F Cole
Journal:  Ann Fam Med       Date:  2003 Nov-Dec       Impact factor: 5.166

10.  Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece.

Authors:  C Kroupis; G Thomopoulou; T G Papathomas; N Vourlidis; A C Lazaris
Journal:  Epidemiol Infect       Date:  2007-06-07       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.